MARATTO

article · PubMed

Association between Diabetes-Related Distress and Medication Adherence among Patients with Type 2 Diabetes Mellitus, Southwest Nigerian.

Abstract

Background: Diabetes-related distress is a common complication that usually impacts the well-being, health outcomes and adherence to medications, especially in individuals with type 2 diabetes mellitus (T2DM). Hence, this study aimed to estimate diabetes-related-distress and its association with medication adherence. Methodology: This is a hospital-based cross-sectional study conducted among 135 patients with T2DM recruited consecutively from a diabetes clinic of a tertiary health institution, Southwest, Nigeria, from March to September 2022. Data were obtained using the Diabetes Distress Scale (DSS-17) questionnaire and Morisky's Medication Adherence Scale (MMAS-8). The association between the dependent variable (DRD) and the independent variable (medication adherence) was assessed with chi-square, and predictors of DSS with logistic regression analysis. The ethical approval was obtained from the committee of the hospital. Results: ). Patients who were highly distressed had 56% lower odds of adhering to their medications compared to those who were not (OR: 0.32, 95% CI: 0.15-0.62). Conclusion: Our findings suggest that diabetes distress is a common issue and significantly determines medication adherence. Thus, incorporating routine screening for distress into the standard diabetes care will be an important intervention to improve adherence and health outcomes of people living with T2DM.

Research topics

  • Medication Adherence and Compliance
  • Diabetes Management and Education
  • Chronic Disease Management Strategies

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.